CardioLogs ECG Analysis Platform vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS

AI Verdict

CardioLogs ECG Analysis Platform provides a broad, AI-powered solution for detecting various arrhythmias from diverse ECG devices. In contrast, the Eko Low Ejection Fraction Tool (ELEFT) is a specialized AI algorithm integrated with Eko digital stethoscopes, focused on the early detection of low ejection fraction, a key indicator of heart failure, by analyzing both ECG and heart sounds. While both leverage AI for cardiac diagnostics, their primary use cases and data input methods target different clinical workflows and specific conditions.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your practice requires a robust, scalable solution for analyzing high volumes of ECG data from a wide range of cardiac monitoring devices, including Holters, smartwatches, and patches. This platform is ideal for specialists focused on comprehensive arrhythmia detection and diagnosis across diverse patient populations, leveraging AI for rapid and accurate insights.

View CardioLogs ECG Analysis Platform →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary care or internal medicine practice needs a quick, non-invasive screening tool to identify patients at risk for heart failure during routine physical examinations. This solution is perfect for integrating early detection of low ejection fraction directly into your workflow using Eko digital stethoscopes, providing rapid results to inform further diagnostic steps.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform Eko Low Ejection Fraction Tool (ELEFT)
Deployment Cloud-based Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs offers broader multi-device compatibility, supporting Holter, smartwatches, and ECG patches, and operates as a vendor-neutral cloud platform. This provides greater flexibility and easier integration into diverse existing clinical workflows. Its customizable reports and EHR integration further enhance its adaptability for various users and settings.

Clinical Value

CardioLogs ECG Analysis Platform

CardioLogs boasts a longer history of FDA clearance (since 2017) and a broader scope of arrhythmia detection across multiple ECG device types. It is supported by over 20 peer-reviewed publications and has demonstrated significant reductions in analysis time and false positives.

Pricing & Value

CardioLogs ECG Analysis Platform

While both tools require contacting sales for specific pricing, CardioLogs offers a more transparent 'pay per ECG regardless of the number of users' model, which can be more predictable and scalable for varying usage volumes. Eko ELEFT is part of a broader 'enterprise solution,' potentially implying a higher or more complex bundled cost.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being cloud-based, FDA-cleared, and HIPAA compliant with explicit BAA availability (or high likelihood for CardioLogs). CardioLogs highlights EHR integration and ISO/IEC 27001 certification, while Eko ELEFT is explicitly positioned as an 'enterprise solution' within its SENSORAu2122 platform and supports telemedicine.

Innovation

Tie

Both tools represent significant innovation in cardiac AI. CardioLogs pioneered medical-grade AI for broad ECG analysis, leveraging deep neural networks and multi-device compatibility to streamline diagnostics. Eko ELEFT innovates by integrating AI with a digital stethoscope for rapid, accessible, and early screening of low ejection fraction during routine physical exams, addressing a critical unmet need.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Eko ELEFT provides a more explicitly detailed and multi-channel support system, including a comprehensive Help Center with FAQs and user manuals, live demos, scheduled calls, and a direct support ticket system. CardioLogs mentions a support center and email, but Eko's offerings appear more robust and transparently laid out for both individual and enterprise customers.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform Eko Low Ejection Fraction Tool (ELEFT)
Name CardioLogs ECG Analysis Platform Eko Low Ejection Fraction Tool (ELEFT)
Company Cardiologs Technologies (now part of Philips) Eko Health
Tagline Reinventing cardiology diagnostics with medical-grade AI and cloud technology. Your new partner in precise, proactive heart and lung care.
Primary Function Rapid, accurate, and efficient analysis of ECG data for arrhythmia detection and diagnosis. Aids clinicians in the early detection of low ejection fraction during routine physical exams.
Key Technology AI-Powered ECG Analysis (Deep Neural Networks) AI-powered low ejection fraction detection, integrates with FDA-cleared Eko digital stethoscopes
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CardioLogs ECG Analysis Platform focuses on rapid, AI-powered analysis of ECG data from various devices to detect and diagnose arrhythmias such as AFib and VT. In contrast, the Eko Low Ejection Fraction Tool (ELEFT) is designed to aid in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
The CardioLogs platform analyzes ECG data from multiple sources, including Holter monitors, smartwatches, and ECG patches. The Eko Low Ejection Fraction Tool (ELEFT) specifically integrates with FDA-cleared Eko digital stethoscopes to analyze both ECG and heart sound recordings.
The Eko Low Ejection Fraction Tool (ELEFT) provides results for low ejection fraction detection in approximately 15 seconds during a routine physical exam. The CardioLogs ECG Analysis Platform offers rapid, accurate, and efficient analysis for arrhythmia detection, but a specific turnaround time is not provided in the given information.
The CardioLogs ECG Analysis Platform is also relevant for Emergency Medicine and Internal Medicine. The Eko Low Ejection Fraction Tool (ELEFT) extends its utility to Family Medicine and Internal Medicine, in addition to Cardiology.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.